This inventor holds 1 USPTO granted patent. Top assignee: Bioventures, LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Rutao Cui
Introduction
Rutao Cui is a notable inventor based in Hangzhou, China. He has made significant strides in the field of immunotherapy, particularly with his work on Mi-2β inhibitors. His innovative approach aims to enhance cancer treatment options through targeted therapies.
Latest Patents
Rutao Cui holds a patent for a Mi-2β inhibitor as an immunotherapy agent. This patent, which is pivotal in cancer treatment, discloses methods for administering an effective amount of a Mi-2β inhibitor to a subject. It also includes techniques for contacting cancer cells or tumors with this inhibitor, showcasing his commitment to advancing medical science.
Career Highlights
Cui is associated with Bioventures, LLC, where he continues to develop and refine his innovative ideas. His work is characterized by a focus on practical applications that can lead to improved patient outcomes in cancer therapy.
Collaborations
Rutao Cui collaborates with esteemed colleagues such as Hong-yu Li and Zhengyu Wang. Their combined expertise contributes to the advancement of research and development in the field of immunotherapy.
Conclusion
Rutao Cui's contributions to the field of immunotherapy through his patent on Mi-2β inhibitors highlight his role as an influential inventor. His work not only reflects his dedication to innovation but also promises to impact cancer treatment significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile